How to Finance a Cosmetic Surgery Center Acquisition

From SBA 7(a) loans to PE-backed capital stacks, understand the financing structures that work for $1M–$5M aesthetic medicine practice acquisitions.

Find Cosmetic Surgery Center Deals SBA Calculator →

Acquiring a cosmetic surgery center requires financing structures that account for healthcare-specific complexity: corporate practice of medicine (CPOM) laws, key-man physician risk, and elective-procedure revenue cyclicality. Most lower middle market deals combine SBA debt, seller notes, and equity to bridge valuation gaps and satisfy lender underwriting standards. Buyers must demonstrate revenue sustainability beyond the selling surgeon to secure institutional financing.

Financing Options for Cosmetic Surgery Center Acquisitions

SBA 7(a) Loan

$500K–$4.5MPrime + 2.75%–3.75% (variable); approximately 10–12% current market

The most common financing vehicle for cosmetic surgery center acquisitions under $5M. SBA 7(a) loans fund up to 90% of the purchase price via an MSO asset purchase structure compatible with CPOM compliance.

Pros

Low down payment (10%) preserves buyer cash for working capital and equipment upgrades post-close
SBA lenders experienced in healthcare are familiar with MSO/PC structures required for CPOM compliance
Loan terms up to 10 years reduce monthly debt service, improving DSCR on practices with 15–25% EBITDA margins

Cons

×Lenders require physician transition agreements and may discount revenue attributable solely to the selling surgeon
×SBA requires personal guarantee and may require life insurance on the acquiring physician or key operator
×Underwriting can take 60–90 days, potentially slower than seller timelines for motivated retirement exits

Seller Financing / Seller Note

$150K–$800K6–8% fixed; subordinated to senior SBA or bank debt

The selling physician defers a portion of proceeds as a subordinated note, typically 10–20% of purchase price. Often used alongside an SBA loan to bridge appraisal gaps or fund earnout periods tied to patient retention.

Pros

Reduces buyer's upfront equity requirement and signals seller confidence in post-close revenue continuity
Enables earnout structuring tied to physician transition milestones, aligning seller incentives with retention
Faster to negotiate than institutional debt; terms are flexible and can accommodate CPOM deal structure nuances

Cons

×Seller note must be subordinated to SBA debt, limiting seller's recourse if buyer defaults post-close
×Selling physicians nearing retirement often resist long note terms beyond 3–5 years, creating balloon risk
×Does not replace equity; buyers still need 5–15% cash injection to satisfy SBA or senior lender requirements

Private Equity / Strategic Acquirer Capital

$2M–$15M+ depending on platform size and EBITDAEquity-based; blended cost of capital 15–25%; seller rollover at 10–20% equity stake

PE-backed aesthetic platform companies or regional cosmetic surgery chains finance add-on acquisitions using equity and institutional credit facilities. Typically requires $2M+ EBITDA and offers rollover equity to the selling surgeon.

Pros

Enables full liquidity event with rollover equity upside for selling physicians who want continued participation
PE platforms provide operational infrastructure — billing, marketing, HR — reducing buyer integration burden post-close
Best path for practices with $2M+ EBITDA that exceed SBA loan limits and attract competitive multi-buyer processes

Cons

×PE buyers impose performance covenants, earnout hurdles, and governance controls that reduce seller autonomy post-close
×Valuations are EBITDA-driven; key-man risk, undocumented revenue, or malpractice history can significantly reduce offers
×Not viable for sub-$1M EBITDA practices; PE platforms typically require proven scalability and associate physician infrastructure

Sample Capital Stack

$2,500,000 (cosmetic surgery center at 4x EBITDA on $625K adjusted EBITDA)

Purchase Price

~$22,500/month total debt service (SBA at 10.5% over 10 years + seller note at 7% over 5 years)

Monthly Service

Approximately 1.35x DSCR on $625K EBITDA after $500K annual debt service — meets SBA minimum 1.25x threshold

DSCR

SBA 7(a) loan: $2,000,000 (80%) | Seller note: $250,000 (10%) | Buyer equity: $250,000 (10%)

Model your own deal structure →

Lender Tips for Cosmetic Surgery Center Acquisitions

1Choose SBA lenders with dedicated healthcare practice lending teams — they understand MSO/PC structures and won't require the deal to be restructured late in underwriting.
2Prepare a physician transition plan documenting how patient relationships will be maintained post-close; lenders will stress-test revenue assuming 15–25% attrition from the selling surgeon.
3Clean up owner add-backs before approaching lenders — aesthetic practices commonly run personal expenses through the business, and unexplained add-backs reduce underwritten EBITDA and loan proceeds.
4Secure malpractice tail insurance commitments before finalizing financing; unresolved tail coverage obligations are a common lender condition that can delay or derail closings.

Frequently Asked Questions

Can I use an SBA loan to buy a cosmetic surgery center if I'm not a physician?

Yes. Non-physician buyers can acquire the management services organization (MSO) entity that handles all non-clinical operations. A licensed physician must own the separate professional corporation (PC) under state CPOM law.

How does key-man dependency affect my ability to get financing?

Lenders will discount revenue heavily attributable to the selling surgeon. Centers where one physician drives 70%+ of revenue face reduced loan proceeds and may require extended seller transition periods as a loan condition.

What EBITDA margin do lenders expect for a cosmetic surgery center acquisition loan?

SBA lenders typically require 15–25% EBITDA margins and a minimum 1.25x DSCR. Centers with strong non-surgical recurring revenue — Botox, fillers, laser — tend to underwrite more favorably due to revenue predictability.

How long does SBA financing take to close for a cosmetic surgery practice acquisition?

Expect 60–90 days from LOI to close with SBA financing. Healthcare transactions add complexity — CPOM review, license verification, malpractice history checks — so engage an SBA healthcare lender at the LOI stage.

More Cosmetic Surgery Center Guides

Buy a Cosmetic Surgery Center Business →Valuation Guide →SBA Loan Guide →Deal Structure →Common Mistakes →SBA Calculator →Deal Structure Builder →

Ready to finance your Cosmetic Surgery Center acquisition?

DealFlow OS surfaces acquisition targets and helps you structure the deal. Free to join.

Start finding deals — free

No credit card required